Low-risk bowel cancer symptoms: is it time for FIT?

作者信息

Kamarudin Mazlan

机构信息

Puzey Family Practice, Rochford, Essex; Primary Care Physician, Multidisciplinary Diagnostic Centre, Southend University Hospital, Essex.

出版信息

Br J Gen Pract. 2019 Jul;69(684):356-357. doi: 10.3399/bjgp19X704501.

DOI:10.3399/bjgp19X704501

PMID:31249095

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6592344/

Abstract

摘要

相似文献

Low-risk bowel cancer symptoms: is it time for FIT?

Br J Gen Pract. 2019 Jul;69(684):356-357. doi: 10.3399/bjgp19X704501.

Colorectal Cancer Screening in the United States: What Is the Best FIT?

Ann Intern Med. 2017 Feb 21;166(4):297-298. doi: 10.7326/M16-2341. Epub 2016 Oct 25.

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Gastroenterology. 2017 Apr;152(5):1217-1237.e3. doi: 10.1053/j.gastro.2016.08.053. Epub 2016 Oct 19.

[Colorectal cancer screening: a work in progress].

Presse Med. 2014 Nov;43(11):1165-7. doi: 10.1016/j.lpm.2014.08.004. Epub 2014 Sep 26.

A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.

Eur J Cancer Prev. 2013 Jul;22(4):299-304. doi: 10.1097/CEJ.0b013e32835b3882.

Which colorectal cancer screening test is best?

J Natl Cancer Inst. 2007 Oct 3;99(19):1424-5. doi: 10.1093/jnci/djm166. Epub 2007 Sep 25.

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Am J Gastroenterol. 2017 Jan;112(1):37-53. doi: 10.1038/ajg.2016.492. Epub 2016 Oct 18.

RE: A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin.

J Natl Cancer Inst. 2015 Oct 16;108(1). doi: 10.1093/jnci/djv312. Print 2016 Jan.

Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges.

Surgeon. 2018 Oct;16(5):302-308. doi: 10.1016/j.surge.2018.01.004. Epub 2018 Mar 13.

Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.

Gastrointest Endosc. 2019 Mar;89(3):518-522. doi: 10.1016/j.gie.2018.08.015. Epub 2018 Aug 22.

本文引用的文献

Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance.

BMC Med. 2017 Oct 24;15(1):189. doi: 10.1186/s12916-017-0944-z.

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Gastroenterology. 2017 Apr;152(5):1217-1237.e3. doi: 10.1053/j.gastro.2016.08.053. Epub 2016 Oct 19.

Use of faecal occult blood tests in symptomatic patients.

BMJ. 2015 Aug 11;351:h4256. doi: 10.1136/bmj.h4256.

A population-based audit of the clinical use of faecal occult blood testing in primary care for colorectal cancer.

Colorectal Dis. 2012 Sep;14(9):e539-46. doi: 10.1111/j.1463-1318.2012.03149.x.

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis.

BMJ. 2010 Jul 15;341:c3369. doi: 10.1136/bmj.c3369.

Miss rate of lung cancer on the chest radiograph in clinical practice.

Chest. 1999 Mar;115(3):720-4. doi: 10.1378/chest.115.3.720.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验